Status:
NOT_YET_RECRUITING
Angiotensin Converting Enzyme Inhibitors in Treatment of Covid 19
Lead Sponsor:
Tanta University
Conditions:
COVID
Eligibility:
All Genders
Phase:
PHASE3
Brief Summary
ACEIs as treatment for COVID19
Detailed Description
ACEIs as suggested treatment for COVID19
Eligibility Criteria
Inclusion
- Patients infected with covid 19
Exclusion
- allergy or contraindications to the drug
Key Trial Info
Start Date :
April 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2029
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04345406
Start Date
April 15 2020
End Date
December 1 2029
Last Update
April 14 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tanta University
Tanta, Egypt, 35111